Daily Journal masthead

New York's attorney general has announced an agreement with Amphastar Pharmaceuticals to extend a nearly 20 percent price cut for naloxone, an antidote for heroin and other opioid overdoses

bug
Share/Save/Bookmark

ALBANY, New York — New York's attorney general has announced an agreement with Amphastar Pharmaceuticals to extend a nearly 20 percent price cut for naloxone, an antidote for heroin and other opioid overdoses.

The attorney general's office says Tuesday that Amphastar for another year will cover a $6 rebate per dose, which will also automatically increase, dollar-for-dollar, to match future growth in the wholesale price.

The rebate is available to the state Health Department, New York City and county governments and the drug treatment centers and harm-reduction programs they fund.

In 2013, more than half of New York City's 782 drug-related overdoses were from heroin.

That year, there were almost 20,000 hospitalizations, most to emergency rooms, related to heroin.

Amphastar is based in Rancho Cucamonga, California.

Think your friends should see this? Share it with them!

Story copyright 2016 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Feedback, Corrections and Other Requests: AP welcomes feedback and comments from readers. Send an email to info@ap.org and it will be forwarded to the appropriate editor or reporter.


We also have more stories about:
(click the phrases to see a list)

Category:

Follow Daily Journal:

All content copyright ©2016 Daily Journal, a publication of AIM Media Indiana unless otherwise noted.
All rights reserved. Privacy policy.